Eledon Pharmaceuticals EBITDA Growth & History (ELDN)

Eledon Pharmaceuticals's calculated EBITDA was −$18.5M for fiscal 2020.

View full Eledon Pharmaceuticals company overview

Eledon Pharmaceuticals annual ebitda history

Eledon Pharmaceuticals annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20202020-12-31−$18.5M−$2.4M
20192019-12-31−$16.0M−$2.0M
20182018-12-31−$14.0M−$950,000
20172017-12-31−$13.1M−$8.0M
20162016-12-31−$5.1M

Eledon Pharmaceuticals ebitda trends

Across the available reported history, Eledon Pharmaceuticals's ebitda decreased from −$16.0M to −$18.5M, a change of −$2.4M. The latest reported quarter, Q4 2020, shows −$6.3M.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Eledon Pharmaceuticals filings at SEC.gov ↗